剖宫产后瘢痕子宫14～27周孕引产方法的比较  

The Effect of Different Methods in Labor Induction for Pregnancy 14～27 Weeks of Scarred Uterus after Cesarean Section

作　　者：魏塞梅 刘炀 李爱明[2] 呼红英[3] 曹引丽 李红梅[5] 高成英[6] 

机构地区：[1]延安市妇幼保健院,陕西延安716000 [2]延安市人民医院妇产科,陕西延安716000 [3]西安市第四人民医院妇产科,陕西西安710004 [4]陕西省妇幼保健院产科,陕西西安710003 [5]延安大学附属医院产科,陕西延安716000 [6]延安大学附属医院妇科,陕西延安716000

出　　处：《现代生物医学进展》2013年第14期2718-2721,共4页Progress in Modern Biomedicine

摘　　要：目的：探讨不同方法对剖宫产后瘢痕子宫中期妊娠（孕14~27周）引产的临床效果。方法：对97例既往有剖宫产史、要求引产的中期妊娠妇女进行回顾性分析,其中单独使用利凡诺的有27例,米非司酮联合利凡诺的有28例,利凡诺联合米索前列醇的有19例,米非司酮联合米索前列醇的有23例,观察采用不同引产方法的孕妇宫缩出现时间、产程、产后出血量及完全流产率的不同。结果：使用米非司酮联合利凡诺、利凡诺联合米索前列醇、米非司酮联合米索前列醇的患者较单独使用利凡诺的患者,其宫缩出现时间及产程均显著性降低,完全流产率均显著性升高,差异有统计学意义（P〈0.05）。结论：米非司酮联合利凡诺、利凡诺联合米索前列醇、米非司酮联合米索前列醇优于单独使用利凡诺进行引产,其宫缩时间及产程均降低,完全流产率升高,值得在临床上推广使用。Objective： To investigate the clinical effectiveness of four different methods in labor induction for mid-pregnancy（14~27 weeks）of scarred uterus after cesarean section.Methods： Retrospective comparative analysis of 97 cases of mid-pregnancy with scarred uterus after cesarean section.There were 27 cases with rivanol alone,28 cases with Mifepristone and rivanol,19 cases with rivanol and misoprostol and 23 cases with mifepristone and misoprostol.To observe the difference of contractions time,stages of labor,the amount of postpartum bleeding and the rate of complete abortion.Results： Compared to the rivanol alone,mifepristone combined with rivanol,rivanol combined with misoprostol and mifepristone combined with misoprostol have significantly lower contractions time and stages of labor and significantly higher rate of complete abortion（P0.05）.Conclusion： Mifepristone combined with rivanol,rivanol combined with misoprostol and mifepristone combined with misoprostol are better methods than the rivanol alone in labor induction for mid-pregnancy of scarred uterus after cesarean section.They can decrease the contractions time and stages of labor and increase the rate of complete abortion.They are worthy of clinical application and promotion.

关 键 词：剖宫产 瘢痕子宫 中期妊娠 引产方法 

分 类 号：R719.3[医药卫生—妇产科学]